Europe's only pharma medical communications summit

Day One Wednesday 28 September 2011

Day One Wednesday 28 September 2011 »

Day Two Thursday 29 September 2011 »

last modified: 16 September '11

8am

Registration & refreshments

CHALLENGES IN MEDICAL COMMUNICATIONS TODAY

8.40am

Opening remarks from chair

8.50am

Key challenges in medical communications today

• Needs of patients versus needs of the industry
• Value-based purchasing - what is value all about?
• Preserving reputation in a world of transparency and blame
• Social media engagement and citizen journalism - managing
whistle-blowing

› Brian Butler,

Managing Director, lines2take

9.10am

How to communicate transparently with physicians and other health care providers via the peer-reviewed scientific literature

• Rethinking the whole approach to publication planning and timing with a view towards providing the academic and medical communities with data as they become available more-or-less in real time

› Dr Gary Evoniuk,

Director of Publication Practices, Medical Communication Quality & Practices, GSK

9.30am

Zen and the art of crisis management - planning, prevention, preparing and performing

• Dealing with the (unexpected) - typology of pharma crises
• Scenario planning - how many backup plans are too many?
• Stakeholders - friend or foe?
• Internal stakeholders / budgets

› Maximilian von Olenhusen,

Director Public Affairs, Novartis

9.50am

How the EMA is regulating the provision of information in medicines

› Juan García Burgos,

Section Head for Public Information and Stakeholder Networking in Medical Information, European Medicines Agency

10.10am

How the US FDA communicates the risks of pharmaceutical products

• Risk-benefit information – results-oriented and adapted to the
audience needs

› Dr Julie Zawisza,

Director, Office of Training and Communication, CDER, FDA

10.30am

Speed networking and morning refreshments

THE NEW PAYER

11.15am

The new NHS and the challenges this presents industry – who will the payer be?

• How do we develop a value story and does this resonate with the NHS
• QIPP vs Value
• Value based pricing – what does this change

› Sam Taylor,

Head, Healthcare Strategy, Pfizer

11.35am

Panel session- Strategies for communicating to the new payers after healthcare reform

› Ole Hauch,

Director of Health Economics and Outcomes Research, AstraZeneca

› Georgina Craig,

Co-lead of the NHS Alliance’s Patient and Public Involvement Network, NHS Alliance

› Patrick Hopkinson,

Director of Market Access and External Affairs, Bristol Myers Squibb

› Dr Peter Patel,

Chief Executive Officer, SBIC

› Ross Carroll,

NHS Foundation Trust Governor and Bow Group Health Analyst, NHS Foundation Trust, Bow Group

WORKING WITH PATIENTS

12.05pm

Providing patients with the right information in the right way

• Ethical considerations; Language requirements; EFPIA guidelines
• The informed patient – the role of media coverage
• The internet – pitfalls and positives

12.25pm

Lunch

1.25pm

Providing the right information to patients across global regions

• Core content & knowledge management for different therapeutic areas

› Sian Slade,

Group Director, Global Medical Information, Bristol-Myers Squibb

1.45pm

Employing user-testing to improve the readability and usability of medicines information

• What is "user testing" and how is it applied to patient package leaflets?
• How can user testing be applied to improve usability of health professional materials?

› Prof Theo Raynor,

Professor of Pharmacy Practice, University of Leeds

2.15pm

Addressing challenges for making patient summaries and ePrescription interoperable

• Examples of successful projects both at national and European level before the epSOS
• Key challenges and obstacles which remain for the epSOS pilot

› Fredrik Linden,

epSOS Project Coordinator, SALAR

2.45pm

Afternoon refreshments

3.15pm

The role of nurses in effective patient communication

› Dr Gabriele Niemczyk,

Medical Affairs, Neurology; Patient and Nurse Communication, Biogen Idec GmbH

3.45pm

Improving healthcare delivery for chronic diseases through better communication

• International partnerships to improve outcomes of diabetes care

› Soren E. Skovlund,

Director, Senior Advisor, Global Patient Research Support, Global Health Partnerships, Novo Nordisk A/S

4.15pm

Developing resources to support country-level affiliates in patient advocacy interactions

• Reaching out to global non-profit cancer organizations and patient advocates

› Cheya Pope,

Senior Director, Patient Navigation, Global Oncology Division, Sanofi-Aventis

4.45pm

Panel session- Is there a patient in the house? - Working alongside patient advocacy groups

• How involvement and participation of patients is vital to good, patient-centred communication
• Keeping communication simple and to the point in our highly regulated world - patients can help us see the wood for the trees
• How patients are creating their own narrative about medicine and health care through social networks and social media

› Simon Denegri,

Chief Executive, Association of Medical Research Charities

› Dr Emma Pennery,

Clinical Director, Breast Cancer Care

› Deborah Rodbard,

Clinical trials database manager, CancerHelp UK

› Keith Allan,

Head of Global Advocacy, Novartis

5.15pm

Closing remarks from the chair

5.25pm

Drinks reception

7.30pm

Gala Dinner

The gala dinner is an opportunity to relax and network over a few drinks and enjoy great food will fellow attendees. More details about this can be found on our website.

Day One Wednesday 28 September 2011 »

Day Two Thursday 29 September 2011 »

last modified: 16 September '11

Sponsor Pharma MedComms World Europe 2011 ›

Session Facilitator